BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27625339)

  • 1. Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.
    Rojas FD; Córdoba SB; de Los Ángeles Sosa M; Zalazar LC; Fernández MS; Cattana ME; Alegre LR; Carrillo-Muñoz AJ; Giusiano GE
    Mycoses; 2017 Feb; 60(2):104-111. PubMed ID: 27625339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.
    Rojas FD; Sosa Mde L; Fernández MS; Cattana ME; Córdoba SB; Giusiano GE
    Med Mycol; 2014 Aug; 52(6):641-6. PubMed ID: 24965946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antifungal activity of azoles and amphotericin B against Malassezia furfur by the CLSI M27-A3 microdilution and Etest
    Galvis-Marín JC; Rodríguez-Bocanegra MX; Pulido-Villamarín ADP; Castañeda-Salazar R; Celis-Ramírez AM; Linares-Linares MY
    Rev Iberoam Micol; 2017; 34(2):89-93. PubMed ID: 28214276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis.
    Prado MR; Brito EH; Brilhante RS; Cordeiro RA; Leite JJ; Sidrim JJ; Rocha MF
    J Microbiol Methods; 2008 Oct; 75(2):341-3. PubMed ID: 18603321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activities of azole agents against the Malassezia species.
    Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
    Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro sensitivity of Malassezia furfur isolates from HIV-positive and negative patients to antifungal agents.
    Ehemann K; Contreras A; Celis-Ramírez AM
    Biomedica; 2023 Aug; 43(Sp. 1):120-131. PubMed ID: 37721914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agar Diffusion Procedures for Susceptibility Testing of Malassezia pachydermatis: Evaluation of Mueller-Hinton Agar Plus 2 % Glucose and 0.5 µg/ml Methylene Blue as the Test Medium.
    Pasquetti M; Chiavassa E; Tizzani P; Danesi P; Peano A
    Mycopathologia; 2015 Oct; 180(3-4):153-8. PubMed ID: 26138434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro combination of antifungal agents against Malassezia pachydermatis.
    Schlemmer KB; de Jesus FPK; Loreto ES; Farias JB; Alves SH; Ferreiro L; Santurio JM
    Med Mycol; 2019 Apr; 57(3):324-327. PubMed ID: 29924372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
    Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
    Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
    Espinel-Ingroff A; Canton E; Gibbs D; Wang A
    J Clin Microbiol; 2007 Mar; 45(3):858-64. PubMed ID: 17215342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
    Claudino AL; Peixoto RF; Melhem MS; Szeszs MW; Lyon JP; Chavasco JK; Franco MC
    Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
    Voelter-Ratson K; Monod M; Unger L; Spiess BM; Pot SA
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():31-6. PubMed ID: 23910390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug susceptibility testing of Malassezia furfur strains to antifungal agents.
    Zissova LG; Kantarjiev TB; Kuzmanov AH
    Folia Med (Plovdiv); 2001; 43(3):10-2. PubMed ID: 11930825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
    Brilhante RSN; Rocha MGD; Guedes GMM; Oliveira JS; Araújo GDS; España JDA; Sales JA; Aguiar L; Paiva MAN; Cordeiro RA; Pereira-Neto WA; Pinheiro AQ; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
    Vet Microbiol; 2018 Jul; 220():47-52. PubMed ID: 29885800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of modified Leeming-Notman media in a resazurin microtiter assay in the evaluation of in-vitro activity of fluconazole against Malassezia furfur ATCC 14521.
    Far FE; Al-Obaidi MMJ; Desa MNM
    J Mycol Med; 2018 Sep; 28(3):486-491. PubMed ID: 29753721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malassezia species: the need to establish epidemiological cutoff values.
    Rojas FD; Sosa MLÁ; Latorre W; Mussin J; Alegre L; Giusiano G
    Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35772016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
    Jesus FP; Lautert C; Zanette RA; Mahl DL; Azevedo MI; Machado ML; Dutra V; Botton SA; Alves SH; Santurio JM
    Vet Microbiol; 2011 Aug; 152(1-2):161-4. PubMed ID: 21658868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and susceptibility profile to classic antifungals and over-the-counter products of Malassezia clinical isolates from a Portuguese University Hospital: a prospective study.
    Pedrosa AF; Lisboa C; Faria-Ramos I; Silva R; Ricardo E; Teixeira-Santos R; Miranda I; Rodrigues AG
    J Med Microbiol; 2019 May; 68(5):778-784. PubMed ID: 30907722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
    Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
    Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
    J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.